RAPT Therapeutics, Inc.
RAPT
$32.01
-$0.32-0.99%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.58M | -17.64M | -17.17M | -53.25M | -18.43M |
| Total Depreciation and Amortization | 205.00K | 228.00K | 252.00K | 287.00K | 297.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.77M | 4.28M | 4.54M | 4.64M | 4.60M |
| Change in Net Operating Assets | 145.00K | 1.86M | -40.04M | 37.88M | -4.08M |
| Cash from Operations | -12.46M | -11.27M | -52.41M | -10.44M | -17.62M |
| Capital Expenditure | 0.00 | -40.00K | -43.00K | -1.00K | -17.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.47M | -7.22M | -57.02M | -842.00K | 18.46M |
| Cash from Investing | 8.47M | -7.26M | -57.06M | -843.00K | 18.45M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 36.00K | 161.00K | -- | 143.12M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 36.00K | 161.00K | -- | 143.12M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.96M | -18.37M | -109.48M | 131.84M | 823.00K |